Man Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-500
Closed -$36K – 2399
2022
Q1
$36K Sell
500
-2,800
-85% -$202K ﹤0.01% 2136
2021
Q4
$303K Buy
+3,300
New +$394K ﹤0.01% 1678

Other funds holding TDOC

Man Group's TDOC Position: Q3 2026 in Review

Man Group increased its Teladoc Health (TDOC) stake by 93% in Q3 2026, buying an estimated $5.52M and bringing the position to 1,566,445 shares worth $9.09M. The position accounts for 0.01% of the portfolio, ranked #875.

Man Group first reported a position in TDOC in Q2 2018 and has held it in 29 quarters since. The position peaked at $42.8M in Q4 2023. 324 funds tracked by Wall St. Rank hold TDOC as of Q3 2026.

  • Man Group held 1,566,445 shares of Teladoc Health worth $9.09M as of Q3 2026.
  • Man Group bought 755,060 Teladoc Health shares in Q3 2026, an estimated $5.52M.
  • Teladoc Health made up 0.01% of Man Group's portfolio in Q3 2026, its #875 holding.
  • Man Group first reported a position in Teladoc Health in Q2 2018 and has held it in 29 quarters since.
  • Man Group's Teladoc Health position peaked at $42.8M in Q4 2023.
  • 324 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2026.

Based on Man Group's 13F filing for Q3 2026, filed 16 Nov 2026.